- €1.77bn
- €4.58bn
- €439.79m
- 31
- 63
- 45
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 200 | 198 | 195 | 262 | 284 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 198 | 195 | 196 | 256 | 279 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 122 | 124 | 197 | 331 | 235 |
Provision for Income Taxes | |||||
Net Income After Taxes | 93.2 | 91.1 | 197 | 232 | 172 |
Net Income Before Extraordinary Items | |||||
Net Income | 93.2 | 91.1 | 197 | 232 | 172 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 93.2 | 91.1 | 197 | 232 | 172 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.523 | 0.514 | 1.01 | 1.18 | 0.912 |
Dividends per Share |